The following is a summary of “How We Do It: Interdisciplinary Diagnosis and Management of Patients With Interstitial Lung Disease and Connective Tissue Disease,” published in the March 2024 issue of Pulmonology by Guler et al.
Diagnosing interstitial lung disease (ILD) in the context of connective tissue disease (CTD) poses significant challenges. Accurately identifying an associated CTD is pivotal for determining prognosis and establishing an optimal treatment strategy. However, diagnostic delays, limited expertise, and fragmented care often hinder the provision of comprehensive healthcare for patients suffering from these rare, complex, and multiorgan conditions. In this article, investigators offer insights on the interdisciplinary diagnosis and interprofessional management of patients with ILD, either suspected or established CTD and those at risk for developing ILD.
Investigators describe the interdisciplinary service’s structure, detailing each team member’s specific roles and responsibilities. Their approach involves close collaboration between rheumatologists and pulmonologists, ensuring thorough assessments and cohesive care plans tailored to the needs of this unique patient population. The study group presents an overview of the patient demographics, diagnostic methodologies, and treatment protocols, supplemented by a representative patient case to illustrate their practices.
Their interdisciplinary consultations offer distinct advantages, such as comprehensive assessments and coordinated care plans, significantly enhancing patient outcomes. However, these consultations also present challenges, including the need for synchronized schedules and effective communication among diverse specialists. Integrating rheumatology and pulmonology expertise is crucial for accurate diagnosis and management in this patient cohort.
Looking ahead, the researchers discuss future directions and potential strategies to enhance care delivery for patients with CTD-ILD. Emphasis is placed on the importance of continuing to refine interdisciplinary approaches, expanding specialist training, and developing robust protocols that address the multifaceted needs of these patients. Through ongoing collaboration and innovation, the study group aims to improve the prognosis and quality of life for individuals affected by CTD-ILD.
Source: sciencedirect.com/science/article/pii/S0012369224002812
